RNA Based Therapeutics Market Is Projected to Gain $25,121.95 Million by 2030: Allied Market Research

The global RNA therapeutics market is driven by the increasing number of government initiatives for large-scale sequencing projects, target specificity, and selectivity of treatment.Wilmington, Delaware, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “RNA Based Therapeutics Market by Disease Type (RNA antisense and RNA interference (RNAi)), Application (Auto-Immune Disorders and Genetic Disorders) and End User (Hospitals & Clinics and Research Institutes): G

Related Keywords

Pune ,Maharashtra ,India ,Delaware ,United States ,United Kingdom ,China ,Qilu ,Gansu ,Hong Kong ,America ,Genzyme Sanofi ,Pawan Kumar ,David Correa ,Arbutus Biopharma Corporation ,Corporation Trust Center ,Alnylam Pharmaceuticals Inc ,Life Sciences ,Drug Administration ,Biogen Inc ,Aerospace Defense ,Market Research ,Gradalis Inc ,Ionis Pharmaceuticals ,Benitec Biopharma Inc ,Business Intelligence Solutions ,Arrowhead Pharmaceuticals ,Healthcare Industry Research ,Semiconductor Electronics ,Energy Power ,Research Institutes ,Therapeutics Market ,Disease Type ,Auto Immune Disorders ,Genetic Disorders ,End User ,Global Opportunity Analysis ,Industry Forecast ,Market Growth ,Therapeutics Market Forecast ,Alnylam Pharmaceuticals ,Qilu Pharmaceutical ,Translate Bio ,Tidal Therapeutics ,Explore More ,North America ,Procurement Information ,Leading Players ,Healthcare Industry Research Studies ,Allied Market Research ,Allied Analytics ,Intelligence Solutions ,Consumer Goods ,Trust Center ,New Castle ,Rna Interference ,Nc ,Lorna Therapeutics ,Herapeutics ,Lions Share ,Major Market Share ,